A. C. Berger, J. C. Watson, E. A. Ross and J. P. Hoffman, “The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma,” The American surgeon, Vol. 70, No. 3, 2004, pp. 235-240.

has been cited by the following article:

• TITLE: Evaluation of Surgical Outcome after Resection of Pancreatic Tumors, Our Experience in Mansoura Oncology Center, a Middle-Volume Center in Egypt

  AUTHORS: Nazem Shams, Mahmoud Mosbah, Mohammad Hegazy, Osama Hussein, Omar Farouk, Sameh Roshdy, Mohamed Tarek Hafez, Ashraf Khater, Khaled Abdel Wahab

  KEYWORDS: Pancreatic Cancer; Whipple; Complication; Survival

  JOURNAL NAME: Journal of Cancer Therapy, Vol.3 No.5, October 17, 2012

  ABSTRACT: Background: Pancreatic cancer is the fourth most common cause of cancer related deaths in the world. Surgical resection remains the only potentially curative treatment for adenocarcinoma of the pancreas; only 10% - 20% of patients are candidate for standard pancreatic resection. Objective: To evaluate perioperative mortality, morbidity and survival for patients underwent PD in middle-volume center. Patients and Methods: Sixty patients with pancreatic tumors were enrolled in this study for different surgical procedure according to type of tumors. Results: No early postoperative complications were observed in 60% of patients, whereas 40% of patients developed one or more complication, the median survival for this group was 12.3 months with standard deviation 3.8 months.